Ben Venue to close: Wither Parenterals?
Ed Silverman at Pharmalot reports today that BI is closing Ben Venue once and for all: More than two years after Ben Venue Laboratories began encountering serious quality…
Menu
September Tips
September is a strange month, isn't it? It's the unofficial end of summer, so we're all getting back into the swing with everyone back in the office. Yet…
How to improve your business development process
At Lacerta Bio, we believe that business development is a process...a process with discrete steps, activities, timeframes, and deliverables. Yet many companies, fully aware of how to run…
Pernix exits generics (sort of)
Texas-based Pernix Therapeutics announced a $30 million divestment of a portfolio of generic assets to Breckenridge: Under the terms of the agreement, Breckenridge will pay…
Perrigo Elan: Markets not happy with Papa
We don't normally comment on stock activity, but the market response to the Perrigo Elan announcement caught our eye: As was pointed out in The Guardian: Perrigo, which…
Biotech Business Development: The Volkswagen Lesson
Just sign a piece a paper and drive off with a new car. They sure make it sound east, don't they? Yet VW does have a good point.…
Stories of Interest in 2012
As we bring 2012 to a close, we're looking back at a few of the interesting events that took place. It was a challenge to whittle this down to a…
The Decline and Fall of The Monitor Empire
While we were recovering from our turkey-induced slumbers, we read the shocking news that Michael Porter's Monitor Group has filed for bankruptcy, and is being acquired by Delloitte . The…
But who will pay?
An intriguing graph was posted on Twitter the other day: Now we understand the argument, and it's a good one: As the population ages, there will be more long-term illness,…
IBD: Problem is worse than we suspected
In researching our latest project, we came across some startling statistics. A report published by the Crohn's and Colotis Foundation of Canada noted: This landmark document revealed that over 200,000…